nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—Prednisolone—chronic obstructive pulmonary disease	0.469	1	CrCtD
Fluoxymesterone—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.0556	0.514	CbGbCtD
Fluoxymesterone—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.0525	0.486	CbGbCtD
Fluoxymesterone—Potassium Canrenoate—Prednisone—chronic obstructive pulmonary disease	0.0165	0.0423	CrCrCtD
Fluoxymesterone—Potassium Canrenoate—Prednisolone—chronic obstructive pulmonary disease	0.0161	0.0413	CrCrCtD
Fluoxymesterone—Danazol—Prednisone—chronic obstructive pulmonary disease	0.0139	0.0357	CrCrCtD
Fluoxymesterone—Hydrocortamate—Prednisone—chronic obstructive pulmonary disease	0.0121	0.0311	CrCrCtD
Fluoxymesterone—Hydrocortamate—Prednisolone—chronic obstructive pulmonary disease	0.0118	0.0303	CrCrCtD
Fluoxymesterone—Cortisone acetate—Prednisone—chronic obstructive pulmonary disease	0.0117	0.0301	CrCrCtD
Fluoxymesterone—Cortisone acetate—Prednisolone—chronic obstructive pulmonary disease	0.0115	0.0294	CrCrCtD
Fluoxymesterone—Testolactone—Prednisone—chronic obstructive pulmonary disease	0.0114	0.0292	CrCrCtD
Fluoxymesterone—Testolactone—Prednisolone—chronic obstructive pulmonary disease	0.0111	0.0285	CrCrCtD
Fluoxymesterone—Amcinonide—Prednisone—chronic obstructive pulmonary disease	0.0105	0.0269	CrCrCtD
Fluoxymesterone—Amcinonide—Prednisolone—chronic obstructive pulmonary disease	0.0102	0.0262	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.0102	0.0262	CrCrCtD
Fluoxymesterone—Fludrocortisone—Prednisone—chronic obstructive pulmonary disease	0.0102	0.0262	CrCrCtD
Fluoxymesterone—Progesterone—Prednisolone—chronic obstructive pulmonary disease	0.00995	0.0255	CrCrCtD
Fluoxymesterone—Fludrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00995	0.0255	CrCrCtD
Fluoxymesterone—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.00995	0.0255	CrCrCtD
Fluoxymesterone—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.00994	0.0255	CrCrCtD
Fluoxymesterone—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.0097	0.0249	CrCrCtD
Fluoxymesterone—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.0097	0.0249	CrCrCtD
Fluoxymesterone—Fluorometholone—Prednisone—chronic obstructive pulmonary disease	0.00947	0.0243	CrCrCtD
Fluoxymesterone—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.00947	0.0243	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Prednisone—chronic obstructive pulmonary disease	0.00947	0.0243	CrCrCtD
Fluoxymesterone—Mometasone—Prednisone—chronic obstructive pulmonary disease	0.00947	0.0243	CrCrCtD
Fluoxymesterone—Loteprednol—Prednisone—chronic obstructive pulmonary disease	0.00947	0.0243	CrCrCtD
Fluoxymesterone—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.00947	0.0243	CrCrCtD
Fluoxymesterone—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.00925	0.0237	CrCrCtD
Fluoxymesterone—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.00925	0.0237	CrCrCtD
Fluoxymesterone—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.00924	0.0237	CrCrCtD
Fluoxymesterone—Fluprednidene Acetate—Prednisolone—chronic obstructive pulmonary disease	0.00924	0.0237	CrCrCtD
Fluoxymesterone—Loteprednol—Prednisolone—chronic obstructive pulmonary disease	0.00924	0.0237	CrCrCtD
Fluoxymesterone—Fluorometholone—Prednisolone—chronic obstructive pulmonary disease	0.00924	0.0237	CrCrCtD
Fluoxymesterone—Mometasone—Prednisolone—chronic obstructive pulmonary disease	0.00924	0.0237	CrCrCtD
Fluoxymesterone—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00903	0.0232	CrCrCtD
Fluoxymesterone—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00903	0.0232	CrCrCtD
Fluoxymesterone—Prednisolone—Prednisone—chronic obstructive pulmonary disease	0.00866	0.0222	CrCrCtD
Fluoxymesterone—Testosterone—Prednisolone—chronic obstructive pulmonary disease	0.00864	0.0222	CrCrCtD
Fluoxymesterone—Hydrocortisone—Prednisone—chronic obstructive pulmonary disease	0.00832	0.0213	CrCrCtD
Fluoxymesterone—Hydrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00812	0.0208	CrCrCtD
Fluoxymesterone—AR—FOXA1 transcription factor network—SCGB1A1—chronic obstructive pulmonary disease	0.000945	0.0467	CbGpPWpGaD
Fluoxymesterone—Polycythaemia—Prednisone—chronic obstructive pulmonary disease	0.000814	0.0708	CcSEcCtD
Fluoxymesterone—Gynaecomastia—Roflumilast—chronic obstructive pulmonary disease	0.000796	0.0693	CcSEcCtD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—SCGB1A1—chronic obstructive pulmonary disease	0.000728	0.0359	CbGpPWpGaD
Fluoxymesterone—AR—FOXA1 transcription factor network—SFTPD—chronic obstructive pulmonary disease	0.000716	0.0354	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—LEP—chronic obstructive pulmonary disease	0.000673	0.0332	CbGpPWpGaD
Fluoxymesterone—ESR1—Estrogen Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.000608	0.03	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—SFTPD—chronic obstructive pulmonary disease	0.000552	0.0272	CbGpPWpGaD
Fluoxymesterone—Coagulopathy—Salbutamol—chronic obstructive pulmonary disease	0.000548	0.0477	CcSEcCtD
Fluoxymesterone—PRLR—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.000521	0.0257	CbGpPWpGaD
Fluoxymesterone—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.000445	0.0387	CcSEcCtD
Fluoxymesterone—Menstruation irregular—Prednisolone—chronic obstructive pulmonary disease	0.000442	0.0384	CcSEcCtD
Fluoxymesterone—ESR1—Estrogen Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.000442	0.0218	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—KL—chronic obstructive pulmonary disease	0.000426	0.021	CbGpPWpGaD
Fluoxymesterone—Hirsutism—Prednisolone—chronic obstructive pulmonary disease	0.000421	0.0366	CcSEcCtD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	0.000399	0.0197	CbGpPWpGaD
Fluoxymesterone—AR—FOXA1 transcription factor network—SERPINA1—chronic obstructive pulmonary disease	0.000387	0.0191	CbGpPWpGaD
Fluoxymesterone—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00033	0.0287	CcSEcCtD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—EGFR—chronic obstructive pulmonary disease	0.000327	0.0161	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—LEP—chronic obstructive pulmonary disease	0.000323	0.016	CbGpPWpGaD
Fluoxymesterone—Menstruation irregular—Prednisone—chronic obstructive pulmonary disease	0.000321	0.0279	CcSEcCtD
Fluoxymesterone—PRLR—Signaling by ERBB4—ERBB3—chronic obstructive pulmonary disease	0.000319	0.0158	CbGpPWpGaD
Fluoxymesterone—Hirsutism—Prednisone—chronic obstructive pulmonary disease	0.000306	0.0266	CcSEcCtD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—SERPINA1—chronic obstructive pulmonary disease	0.000298	0.0147	CbGpPWpGaD
Fluoxymesterone—Alopecia—Aminophylline—chronic obstructive pulmonary disease	0.000263	0.0229	CcSEcCtD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—GCLC—chronic obstructive pulmonary disease	0.000263	0.013	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	0.000254	0.0125	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—LEP—chronic obstructive pulmonary disease	0.000248	0.0122	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.000234	0.0204	CcSEcCtD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—CYP1A2—chronic obstructive pulmonary disease	0.000221	0.0109	CbGpPWpGaD
Fluoxymesterone—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.00022	0.0191	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000219	0.0108	CbGpPWpGaD
Fluoxymesterone—Clobetasol propionate—CYP1A1—chronic obstructive pulmonary disease	0.000215	0.188	CrCbGaD
Fluoxymesterone—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.0187	CcSEcCtD
Fluoxymesterone—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.0186	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000212	0.0184	CcSEcCtD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000208	0.0103	CbGpPWpGaD
Fluoxymesterone—Clobetasol propionate—CYP1A2—chronic obstructive pulmonary disease	0.000208	0.181	CrCbGaD
Fluoxymesterone—PRLR—Immune System—RAPGEF3—chronic obstructive pulmonary disease	0.000205	0.0101	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—TGFB2—chronic obstructive pulmonary disease	0.000204	0.0101	CbGpPWpGaD
Fluoxymesterone—Amenorrhoea—Prednisone—chronic obstructive pulmonary disease	0.000202	0.0176	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—LY96—chronic obstructive pulmonary disease	0.0002	0.00986	CbGpPWpGaD
Fluoxymesterone—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000199	0.0173	CcSEcCtD
Fluoxymesterone—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000188	0.0164	CcSEcCtD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC2—chronic obstructive pulmonary disease	0.000186	0.00921	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	0.000185	0.00912	CbGpPWpGaD
Fluoxymesterone—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000183	0.016	CcSEcCtD
Fluoxymesterone—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000179	0.0156	CcSEcCtD
Fluoxymesterone—Dexamethasone—NOS2—chronic obstructive pulmonary disease	0.000176	0.153	CrCbGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL13—chronic obstructive pulmonary disease	0.000168	0.0083	CbGpPWpGaD
Fluoxymesterone—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.000167	0.0146	CcSEcCtD
Fluoxymesterone—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.000167	0.0146	CcSEcCtD
Fluoxymesterone—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000164	0.0143	CcSEcCtD
Fluoxymesterone—ESR1—Regulation of Telomerase—HDAC2—chronic obstructive pulmonary disease	0.000164	0.00808	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.000162	0.00798	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000161	0.014	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000161	0.014	CcSEcCtD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—CYP1A1—chronic obstructive pulmonary disease	0.000161	0.00793	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00016	0.00791	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	0.00016	0.00791	CbGpPWpGaD
Fluoxymesterone—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.0138	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000158	0.0137	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000156	0.0136	CcSEcCtD
Fluoxymesterone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000152	0.0132	CcSEcCtD
Fluoxymesterone—PRLR—Adipogenesis—TNF—chronic obstructive pulmonary disease	0.00015	0.00739	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000147	0.0128	CcSEcCtD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	0.000142	0.00702	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000142	0.0123	CcSEcCtD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	0.00014	0.00692	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	0.00014	0.00691	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—chronic obstructive pulmonary disease	0.000139	0.00685	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	0.000139	0.00685	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000137	0.0119	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000133	0.00655	CbGpPWpGaD
Fluoxymesterone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000133	0.0115	CcSEcCtD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.000132	0.00654	CbGpPWpGaD
Fluoxymesterone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	0.000128	0.00633	CbGpPWpGaD
Fluoxymesterone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000126	0.0109	CcSEcCtD
Fluoxymesterone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000125	0.0109	CcSEcCtD
Fluoxymesterone—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.0107	CcSEcCtD
Fluoxymesterone—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000123	0.0107	CcSEcCtD
Fluoxymesterone—ESR1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000123	0.00605	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	0.000121	0.00598	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—IL6—chronic obstructive pulmonary disease	0.000121	0.00596	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000121	0.00596	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.000119	0.0059	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	0.000119	0.00589	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000119	0.0103	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000119	0.0103	CcSEcCtD
Fluoxymesterone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000119	0.0103	CcSEcCtD
Fluoxymesterone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000116	0.0101	CcSEcCtD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000116	0.00572	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	0.000115	0.00566	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—NOS3—chronic obstructive pulmonary disease	0.000115	0.00566	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000112	0.00975	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL1B—chronic obstructive pulmonary disease	0.000112	0.00551	CbGpPWpGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	0.000111	0.0055	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	0.000108	0.00532	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	0.000107	0.00526	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000106	0.00526	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	0.000106	0.00524	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	0.000103	0.00509	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	0.000101	0.00501	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	0.000101	0.00499	CbGpPWpGaD
Fluoxymesterone—Headache—Formoterol—chronic obstructive pulmonary disease	0.000101	0.00878	CcSEcCtD
Fluoxymesterone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000101	0.00878	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000101	0.00497	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.0001	0.00496	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	9.96e-05	0.00492	CbGpPWpGaD
Fluoxymesterone—Headache—Montelukast—chronic obstructive pulmonary disease	9.88e-05	0.0086	CcSEcCtD
Fluoxymesterone—NR3C1—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	9.63e-05	0.00475	CbGpPWpGaD
Fluoxymesterone—Nausea—Formoterol—chronic obstructive pulmonary disease	9.57e-05	0.00833	CcSEcCtD
Fluoxymesterone—Nausea—Arformoterol—chronic obstructive pulmonary disease	9.57e-05	0.00833	CcSEcCtD
Fluoxymesterone—Headache—Salbutamol—chronic obstructive pulmonary disease	9.53e-05	0.00829	CcSEcCtD
Fluoxymesterone—ESR1—Leptin signaling pathway—LEP—chronic obstructive pulmonary disease	9.43e-05	0.00466	CbGpPWpGaD
Fluoxymesterone—Nausea—Montelukast—chronic obstructive pulmonary disease	9.37e-05	0.00816	CcSEcCtD
Fluoxymesterone—NR3C1—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	9.34e-05	0.00461	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	9.25e-05	0.00457	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—MMP9—chronic obstructive pulmonary disease	9.19e-05	0.00454	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—TLR2—chronic obstructive pulmonary disease	9.07e-05	0.00448	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	9.06e-05	0.00448	CbGpPWpGaD
Fluoxymesterone—Nausea—Salbutamol—chronic obstructive pulmonary disease	9.03e-05	0.00786	CcSEcCtD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	9.03e-05	0.00446	CbGpPWpGaD
Fluoxymesterone—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	8.97e-05	0.0078	CcSEcCtD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	8.94e-05	0.00441	CbGpPWpGaD
Fluoxymesterone—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	8.92e-05	0.00777	CcSEcCtD
Fluoxymesterone—Progesterone—CYP1A1—chronic obstructive pulmonary disease	8.81e-05	0.0769	CrCbGaD
Fluoxymesterone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	8.72e-05	0.00759	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—KL—chronic obstructive pulmonary disease	8.53e-05	0.00421	CbGpPWpGaD
Fluoxymesterone—Progesterone—CYP1A2—chronic obstructive pulmonary disease	8.5e-05	0.0741	CrCbGaD
Fluoxymesterone—Norethindrone—ALB—chronic obstructive pulmonary disease	8.42e-05	0.0735	CrCbGaD
Fluoxymesterone—Testosterone—CYP1A1—chronic obstructive pulmonary disease	8.33e-05	0.0727	CrCbGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	8.28e-05	0.00409	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.11e-05	0.004	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—CYP1A1—chronic obstructive pulmonary disease	8.06e-05	0.0703	CrCbGaD
Fluoxymesterone—Methyltestosterone—ALB—chronic obstructive pulmonary disease	8e-05	0.0698	CrCbGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—KL—chronic obstructive pulmonary disease	7.99e-05	0.00395	CbGpPWpGaD
Fluoxymesterone—Alopecia—Prednisone—chronic obstructive pulmonary disease	7.88e-05	0.00686	CcSEcCtD
Fluoxymesterone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	7.83e-05	0.00682	CcSEcCtD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—chronic obstructive pulmonary disease	7.73e-05	0.00381	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—CXCL8—chronic obstructive pulmonary disease	7.59e-05	0.00375	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—VEGFA—chronic obstructive pulmonary disease	7.53e-05	0.00372	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	7.33e-05	0.00362	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	7.23e-05	0.00357	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	7.08e-05	0.00349	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—NOS3—chronic obstructive pulmonary disease	7.07e-05	0.00349	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—chronic obstructive pulmonary disease	6.99e-05	0.00345	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	6.96e-05	0.00344	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CD8A—chronic obstructive pulmonary disease	6.87e-05	0.00339	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	6.85e-05	0.00338	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—EGFR—chronic obstructive pulmonary disease	6.77e-05	0.00334	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	6.62e-05	0.00327	CbGpPWpGaD
Fluoxymesterone—Anxiety—Prednisone—chronic obstructive pulmonary disease	6.59e-05	0.00574	CcSEcCtD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	6.54e-05	0.00323	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	6.52e-05	0.00322	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—TNF—chronic obstructive pulmonary disease	6.45e-05	0.00318	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	6.43e-05	0.00559	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—ERBB3—chronic obstructive pulmonary disease	6.39e-05	0.00316	CbGpPWpGaD
Fluoxymesterone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	6.34e-05	0.00552	CcSEcCtD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	6.28e-05	0.0031	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—IL1B—chronic obstructive pulmonary disease	6.01e-05	0.00297	CbGpPWpGaD
Fluoxymesterone—ESR1—LKB1 signaling events—TP53—chronic obstructive pulmonary disease	6e-05	0.00296	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	5.99e-05	0.00296	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—ERBB3—chronic obstructive pulmonary disease	5.99e-05	0.00296	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	5.98e-05	0.00295	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.93e-05	0.00293	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	5.9e-05	0.00291	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—CRP—chronic obstructive pulmonary disease	5.84e-05	0.00289	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	5.75e-05	0.00284	CbGpPWpGaD
Fluoxymesterone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	5.69e-05	0.00495	CcSEcCtD
Fluoxymesterone—PRLR—Immune System—TLR4—chronic obstructive pulmonary disease	5.6e-05	0.00277	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	5.57e-05	0.00275	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	5.56e-05	0.00275	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.51e-05	0.00272	CbGpPWpGaD
Fluoxymesterone—Headache—Prednisolone—chronic obstructive pulmonary disease	5.46e-05	0.00476	CcSEcCtD
Fluoxymesterone—AR—Androgen receptor signaling pathway—EGFR—chronic obstructive pulmonary disease	5.19e-05	0.00256	CbGpPWpGaD
Fluoxymesterone—Nausea—Prednisolone—chronic obstructive pulmonary disease	5.18e-05	0.00451	CcSEcCtD
Fluoxymesterone—PRLR—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.09e-05	0.00251	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—TGFB1—chronic obstructive pulmonary disease	5.05e-05	0.00249	CbGpPWpGaD
Fluoxymesterone—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	4.98e-05	0.00246	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	4.95e-05	0.00245	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—EGFR—chronic obstructive pulmonary disease	4.95e-05	0.00245	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	4.94e-05	0.00244	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	4.86e-05	0.0024	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	4.69e-05	0.00232	CbGpPWpGaD
Fluoxymesterone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	4.67e-05	0.00406	CcSEcCtD
Fluoxymesterone—Testosterone—ALB—chronic obstructive pulmonary disease	4.64e-05	0.0405	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.55e-05	0.00224	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	4.53e-05	0.00224	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	4.34e-05	0.00214	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—IL6—chronic obstructive pulmonary disease	4.27e-05	0.00211	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.13e-05	0.00204	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	4.11e-05	0.00203	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	4.06e-05	0.00201	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	4e-05	0.00198	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.98e-05	0.00196	CbGpPWpGaD
Fluoxymesterone—Headache—Prednisone—chronic obstructive pulmonary disease	3.97e-05	0.00346	CcSEcCtD
Fluoxymesterone—ESR1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	3.82e-05	0.00188	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.77e-05	0.00186	CbGpPWpGaD
Fluoxymesterone—Nausea—Prednisone—chronic obstructive pulmonary disease	3.76e-05	0.00328	CcSEcCtD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	3.76e-05	0.00186	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	3.72e-05	0.00184	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.7e-05	0.00183	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.68e-05	0.00182	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	3.66e-05	0.00181	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL1B—chronic obstructive pulmonary disease	3.65e-05	0.0018	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	3.53e-05	0.00174	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	3.44e-05	0.0017	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.4e-05	0.00168	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	3.3e-05	0.00163	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	3.23e-05	0.00159	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.15e-05	0.00156	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.13e-05	0.00154	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	2.96e-05	0.00146	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.91e-05	0.00144	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.9e-05	0.00143	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.87e-05	0.00142	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.85e-05	0.00141	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.81e-05	0.00139	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	2.79e-05	0.00138	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—EGFR—chronic obstructive pulmonary disease	2.78e-05	0.00137	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.77e-05	0.00137	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	2.77e-05	0.00137	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.68e-05	0.00132	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.62e-05	0.00129	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—EGFR—chronic obstructive pulmonary disease	2.6e-05	0.00129	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.54e-05	0.00126	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	2.49e-05	0.00123	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.46e-05	0.00121	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.41e-05	0.00119	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	2.39e-05	0.00118	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CTGF—chronic obstructive pulmonary disease	2.39e-05	0.00118	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.36e-05	0.00117	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	2.26e-05	0.00112	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	2.23e-05	0.0011	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—HDAC2—chronic obstructive pulmonary disease	2.22e-05	0.0011	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.22e-05	0.0011	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.21e-05	0.00109	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.2e-05	0.00108	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.17e-05	0.00107	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL6—chronic obstructive pulmonary disease	2.13e-05	0.00105	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.07e-05	0.00102	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—chronic obstructive pulmonary disease	2e-05	0.000988	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2e-05	0.000985	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	1.93e-05	0.000953	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	1.89e-05	0.000933	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CTGF—chronic obstructive pulmonary disease	1.84e-05	0.000907	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.83e-05	0.000904	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	1.82e-05	0.000899	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	1.81e-05	0.000894	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.8e-05	0.000887	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	1.74e-05	0.000859	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	1.71e-05	0.000846	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	1.71e-05	0.000845	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	1.69e-05	0.000833	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.52e-05	0.000752	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.51e-05	0.000744	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.38e-05	0.000681	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.11e-05	0.00055	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.09e-05	0.000537	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.04e-05	0.000511	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	9.55e-06	0.000472	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	8.54e-06	0.000421	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	8.38e-06	0.000414	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	8.25e-06	0.000407	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	7.76e-06	0.000383	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	7.47e-06	0.000369	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	6.94e-06	0.000343	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	5.45e-06	0.000269	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	5.2e-06	0.000257	CbGpPWpGaD
Fluoxymesterone—SHBG—connective tissue—chronic obstructive pulmonary disease	4.86e-06	0.113	CbGeAlD
Fluoxymesterone—ESR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	4.61e-06	0.000228	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	4.17e-06	0.000206	CbGpPWpGaD
Fluoxymesterone—ESR1—respiratory system—chronic obstructive pulmonary disease	3.89e-06	0.0902	CbGeAlD
Fluoxymesterone—ESR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	3.75e-06	0.000185	CbGpPWpGaD
Fluoxymesterone—AR—connective tissue—chronic obstructive pulmonary disease	3.49e-06	0.0809	CbGeAlD
Fluoxymesterone—ESR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	3.44e-06	0.00017	CbGpPWpGaD
Fluoxymesterone—ESR1—connective tissue—chronic obstructive pulmonary disease	3.42e-06	0.0794	CbGeAlD
Fluoxymesterone—ESR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	3.37e-06	0.000166	CbGpPWpGaD
Fluoxymesterone—AR—bronchus—chronic obstructive pulmonary disease	3.26e-06	0.0756	CbGeAlD
Fluoxymesterone—AR—smooth muscle tissue—chronic obstructive pulmonary disease	3.19e-06	0.074	CbGeAlD
Fluoxymesterone—ESR1—smooth muscle tissue—chronic obstructive pulmonary disease	3.13e-06	0.0726	CbGeAlD
Fluoxymesterone—NR3C1—respiratory system—chronic obstructive pulmonary disease	2.87e-06	0.0665	CbGeAlD
Fluoxymesterone—ESR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.83e-06	0.00014	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	2.59e-06	0.000128	CbGpPWpGaD
Fluoxymesterone—NR3C1—connective tissue—chronic obstructive pulmonary disease	2.53e-06	0.0586	CbGeAlD
Fluoxymesterone—NR3C1—bronchus—chronic obstructive pulmonary disease	2.36e-06	0.0548	CbGeAlD
Fluoxymesterone—NR3C1—smooth muscle tissue—chronic obstructive pulmonary disease	2.31e-06	0.0536	CbGeAlD
Fluoxymesterone—NR3C1—trachea—chronic obstructive pulmonary disease	2.12e-06	0.0492	CbGeAlD
Fluoxymesterone—AR—lung—chronic obstructive pulmonary disease	2.1e-06	0.0488	CbGeAlD
Fluoxymesterone—ESR1—lung—chronic obstructive pulmonary disease	2.07e-06	0.0479	CbGeAlD
Fluoxymesterone—NR3C1—lung—chronic obstructive pulmonary disease	1.52e-06	0.0353	CbGeAlD
